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Abstract
Background: A previous study showed that combination of zinc and vitamin A reduced sputum conversion time 
in pulmonary tuberculosis (TB) patients.
Objective: We studied the efficacy of which single micronutrient contributed more to the sputum conversion 
time.
Methods: In a double-blind randomized com m unity trial, newly sputum smear positive pulmonary TB patients 
were assigned randomly to receive zinc, vitamin A, zinc +  vitamin A or placebo on top of TB treatment. Patients 
were asked to deliver their sputum on weekly basis to measure positivity of the bacteria. Nutritional status, chest 
x-ray, hem oglobin, C-reactive protein (CRP), retinol and zinc level were examined prior to, after 2 and 6 months 
of treatment.
Results: Initially, 300 patients were enrolled, and 255 finished the treatment. Most patients were severely 
malnourished (mean BMI 16.5 ±  2.2 Kg/m 2). Patients in the zinc +  vitamin A group showed earlier sputum 
conversion time (mean 1.9 weeks) compared with that in the other groups; however the difference was not 
significant. Also, no benefit could be demonstrated of any of the used supplementations on clinical, nutritional, 
chest x-ray, or laboratory findings.
Conclusions: This study am ong severely malnourished TB patients, did not confirm that single or combined 
supplementation of zinc and vitamin A significantly reduced sputum conversion time or had other significant 
benefit.
Background
T he p resence of m ic ro n u trien t deficiencies am ong 
tubercu losis  (TB) p a tien ts  has led to  the question  
w hether m ic ro n u trien t supp lem en ta tio n  w ould give 
additional benefits for the patien ts on top of the TB 
treatm en t [1]. In a previous clinical trial of our group 
found that com bination of zinc and vitamin A supple­
m entation  resulted in earlier sputum  conversion than
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placebo, w hich began as early as 2 weeks after the 
administration of standard anti-TB treatm ent [2].
V itam in A, as found as retinol in plasma, is one of 
im portan t m ic ronu trien t w hich has specific im m une 
function [3]. The presence of vitam in A deficiency in 
sputum-positive pulmonary TB patients compared with 
healthy subjects was confirm ed [1,4 ]. and associated 
with the future of pulmonary adult TB patients [5].
Zinc is a trace mineral, which is essential for the func­
tion of cells of the immune system, [6] and a mild defi­
ciency depresses the im m une function in hum ans [7]. 
Zinc is also known as an essential m ineral for norm al
© 2010 Pakasi et al; licensee BioMed Central Ltd. This is an O pen Access article distributed under the term s o f the Creative C om m ons 
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mobilization of vitamin A from the liver to the plasma 
[8].
As in other programs for the combat against TB, the 
National Tuberculosis Program  in Indonesia states that 
the disappearance of acid-fast bacilli (AFB) from sputum 
after treatm ent is basic in pulmonary TB patients' m an­
agem ent. The p resence of AFB in sp u tu m  can be 
assessed by direct visualization using the light m icro­
scope, and can be confirmed by growth of Mycobacter­
ium  tuberculosis  in  sp u tu m  cu lture . C onversion  of 
sputum  sm ears to AFB-negative status is only used in 
resource-limited countries [9] while in developed coun­
tries treatm ent success is measured by conversion to no 
growth of Mycobacterium tuberculosis (MTB) in sputum 
culture [10].
The effectiveness of anti-TB therapy is determined by 
several factors, including the burden of mycobacteria, 
underlying immune status, adherence to treatm ent, and 
drug susceptibility. In the face of new threats to combat 
tuberculosis, i.e. m ultidrug and extensively drug resis­
tance MTB, and also immunosuppressive diseases (HIV, 
diabetes, malnutrition); the studies on m icronutrients as 
m od u la to r of the im m une system  are im p o rtan t. It 
would provide more evidence to the importance of sup­
p lem entation  against tuberculosis. Following the p re­
vious finding in  Jakarta, the  p resen t study aim ed to 
investigate the effect of single supplem entation of zinc 
or vitamin A or the combinations, on the sputum  con­
version time and the health status of newly diagnosed 
pulm onary TB patients. The study was done in N usa 
Tenggara Tim ur (NTT) province which was selected on 
purpose, because of its relatively poorer than in Jakarta 
with high prevalence of m alnutrition and vulnerable of 
food insecurity as reported by the ministry of health in 
2005.
Methods
Study design, time and location
The design of the study was a double-blind, randomized 
community trial. Prior to the study, random ization was 
done using a com puter program, in which a treatm ent 
code was given to a subject. Every district had its ran ­
dom  allocation table consisted 60 patien ts plus addi­
tional random iza tion  for an o th e r 50 patien ts , to 
an tic ipate  if one d is tric t had m ore p a tien t th an  the 
other.
Patients were given standard  trea tm en t for TB and 
random ly divided in to  four supp lem entation  groups: 
zinc alone, vitamin A alone, zinc + vitamin A, and pla­
cebo. The su pp lem en ta tion  was taken  daily and the 
patients were followed up until 6 months.
The prim ary outcom e of the study was sputum  con­
version time. Secondary outcomes were: nutritional sta­
tus (BMI, MUAC, % of body fat), abnormalities on chest
x-ray, and results of blood examinations (CRP, plasma 
concentrations of zinc and vitamin A).
The study was conducted in N usa Tenggara T im ur 
(NTT) Province, Indonesia, covering four districts in 
Timor and Rote Island, namely Kupang City (the capital 
of NTT), Kupang District, Tim or Tengah Utara (TTU- 
N orthern  C entral Timor) district and Rote-N dao dis­
trict, from January 2004 until December 2005.
Subjects and sample size
Subjects were newly diagnosed sputum  smear-positive 
(SS+) TB patients aged 15-55 years. Prior and during 
the study, all pregnant or lactating females and subjects 
who had underlying chronic or degenerative disease, 
were excluded. All eligible patients were given informa­
tion regarding the study including problems that might 
occur; and were asked to sign an informed consent for 
their participations in the study. The sample size was 
calculated based on the ability to determine a difference 
w ith a  = 0.05 and 1-ß = 0.80 in  sp u tum  conversion 
time, nutritional status (BMI) and plasma concentrations 
of retinol and zinc. As plasma retinol concentration was 
the param eter requiring the largest sample size, it was 
calculated th a t w ith a m inim um  sam ple size of 40 in 
each group, a between-group difference of 0.12 ^mol/L 
in plasma retinol level could be detected based on the 
previous study.2 A ccounting for a 40% drop-ou t rate, 
each group in the intervention study comprised at least
56 subjects.
Micronutrient supplementation and anti-TB drugs
Supplements and placebo were prepared by Kimia Farma 
Ltd, Indonesia, in the form of capsules. Each m icronutri­
ent capsule contained 1500 retinol equivalents (5000 IU) 
vitamin A (as retinyl acetate) and/or 15 mg zinc (as zinc 
sulfate) in a lactose matrix. Dosage of zinc was determined 
based on the recom m ended daily allowances for adult 
Indonesians. Based on the previous study in  Jakarta, 
dosage of zinc was 15 mg in a form of zinc sulfate [2]. The 
vitamin A given in the capsule was twice of the Indonesian 
RDA, considering the possible deficiency and needs 
to overcome inflammation process. As found in the pre­
vious study in Jakarta, 5000 IU of vitamin A in combina­
tion with zinc, was considered adequate and used in the 
current study [2]. The placebo capsule consisted of lactose 
alone. All capsules were similar in term s of shape, color 
and size. Standard TB drugs were based on W HO guide­
lines, com prising 300 mg isoniazid, 450 mg rifampicin, 
1500 mg pyrazinamide and 750 mg ethambutol daily for 
2 m onths, followed by 600 mg isoniazid and 450 mg 
rifampicin three times a week during the next 4 months. 
To ensure adherence to the treatment, each patient had a 
trea tm en t-p artn e r as recom m ended by W H O  in the 
DOTS strategy. The trea tm en t-p artn e r 's  task was to
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observe patients' compliance and to report whenever pro­
blems occurred regarding TB treatment. They got money 
w hen successfully m aintained the trea tm en t as it was 
given by the donor of th is study. C om pliance of the 
patients was measured monthly by the report of the treat­
ment partner, double cross-checked with the blister of the 
TB drugs; as for the supplementation, we counted the left 
over capsules that should be taken every month.
Data collection
All patients underw ent physical examination, chest x- 
ray, nutritional and food intake assessment as described 
in other study [5], and blood analyses before the treat­
m ent started, after the intensive phase, and at the end 
of the treatment, except for sputum  examination, which 
was done weekly. HIV testing was not carried out since 
the area is still known as a low prevalence area for HIV 
infection, as well as for HIV-TB co-infection [11].
Sputum conversion time
During the first 2 m onths of the study, the patients were 
asked to  come to the clinic every week to  deliver their 
sputum  for direct AFB sm ear examination. Three early 
morning sputum specimens were taken from the patients 
and examined by direct microscopy after Ziehl-Neelsen 
staining in each Health Centre. The time was noted when 
the first of three weeks' consecutive sputum  sm ears of 
good quality was negative. In the case that either, not all 
sputum samples were delivered, or the sputum was not of 
adequate quality, the data were considered missing.
Chest x-ray examination
Chest X-rays were performed at diagnosis on all patients 
and were evaluated by calculating the visible lesion area 
in both lungs. In patients with cavities, the total area of 
exposed cavity wall was calculated from  the radius of 
visible cavities (nr2) as described before [2].
Nutritional status
N utritional status was determ ined based on anthropo­
metric m easurements and m icronutrient concentrations 
in  the  plasm a. The an th ro p o m etric s  m easurem ents 
were: body weight, height, body m ass index, skinfold 
thickness and percentage of body fat.
Body weight was assessed using an electronic platform 
model weighing scale (770 alpha; SECA, Hamburg, Ger­
many) to the nearest 0.1 kg. Height was recorded to the 
nearest 0.1 cm using a microtoise. BMI was calculated 
as body weight divided by height squared (kg/m2). Mid 
upper arm  circumference (MUAC) was m easured using 
a flexible m easurem ent tape. Skinfold th ickness was 
m easured at 4 sites: biceps, triceps, sub-scapular, and 
supra-iliac regions, w ith a slim guide skinfold callipers 
(Creative health product, Plymouth, Michigan, 48170), 
recorded to the nearest 0.2 mm. The percentage of total 
body fat was based on the skinfold data, and calculated 
using the Durnin and Wormesley equations [12].
Blood examination
Blood sam ples were collected betw een 08.00 and 
10.00 AM in the local health center. Approximately 15 mL 
of fasting whole blood was withdrawn and separated into 
4 vacutainers (Becton Dickinson, Rutherford, NJ) contain­
ing EDTA and heparin. Zinc and vitamin A concentration 
were measured in plasma. C-reactive protein (CRP) was 
m easured to adjust the m icronutrient deficiency in the 
statistical analysis. Plasma was separated after centrifuga­
tion at 750 x g for 10 minutes at room temperature, and 
then stored at minus 20°C until analyzed for CRP, retinol, 
and zinc concen tra tion  at the SEAMEO-TROPMED 
Laboratory, Jakarta. C-reactive protein (CRP) was m ea­
sured using enzyme-linked immunosorbent assay (ELISA) 
m ethod w ith a norm al value < 10 mg/L. Plasma retinol 
concentration was measured by high performance liquid 
chrom atography (HPLC), values less than 0.70 ^mol/L 
were regarded as indicating deficiency, and values between 
0.70 ^mol/L and 1.4 ^mol/L indicates marginal deficiency 
[13]. Plasma zinc was analyzed using atomic absorption 
spectrom etry (AAS) with values >10.7 ^mol/L regarded 
as normal. Determination of hemoglobin, WBC, and ESR 
were done on the same day at the provincial hospital 
laboratory. Hemoglobin and WBC were analyzed using 
autom atic analyzer (ABX M icros 60, French). The cu t­
off points for norm al hem oglobin were >120 g/L and 
>130 g/L for females and males respectively, and ESR was 
assessed using Westengren technique with a normal value 
< 20 mm/h. Serum albumin was measured using Spectro­
pho tom eter (M icrolab 300, M erck, Germany) w ith a 
normal range 35-52 g/L.
Statistical analysis
A one-sam ple Kolm ogorov-Sm irnov test was used to 
determine whether the variables were normally distribu­
ted. Data on the characteristics of the subjects at enroll­
m ent for their age and gender distribution, nutritional 
status, blood concentrations, and results of radiological 
signs were summarized and used to assess the com par­
ability of the patien ts random ly assigned to the four 
treatm ent groups. Different means between groups were 
tested  for significance using one-way ANOVA w hen 
normally distributed, and Kruskal-Wallis test when not- 
normally distributed. An extended analysis (ANCOVA) 
was further applied for determ ining predictors of ou t­
come. Different proportions between groups were tested 
using ch i-squared  test. W ith in  group changes were 
tested using paired student-t test for normally distribu­
ted data and the W ilcoxon signed-rank when for not- 
norm ally  d istribu ted . A p value less th an  0.05 were 
considered significant. An intention to treat analysis was 
applied. Statistical analyses were performed using com­
p u te r softw are SPSS for W indow s PC version 14.0 
(SPSS Inc, Chicago, IL, USA) [14].
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Ethical considerations
This study  adhered  to  the Council for In te rna tiona l 
Organizations of Medical Sciences guidelines (CIOMS, 
1991). Data were collected after subjects agreed to parti­
cipate in the study and gave w ritten inform ed consent 
voluntarily. The research proposal was approved by the 
Ethics Committee of the Faculty of Medicine, University 
of Indonesia.
Results
A total of 300 patients were enrolled into the study and 
randomly grouped into 4 categories of intervention, i.e. 
supplem entation of zinc (n = 76), vitam in A (n = 72), 
com bined zinc + vitamin A (n = 66) and placebo (n = 
86). A fter two m on ths 274 p atien ts  were still in the 
study and analyzed, while 255 patients com pleted the 
study after 6 m onths and were analyzed. (Figure 1). Of 
all subjects, we received report from the treatm ent-part­
ners th a t 22 patien ts  (of to ta l 255 p a tien ts  who
com pleted TB treatm ent) were no t com pliance to the 
study procedure.
Patients' m ean age was 31.5 years and 63% of them  
were men (Table 1). Sputum positivity grade 3 was most 
prevalent. The prevalence of cavities on chest X-ray was 
almost 40% for all groups. These findings suggested that 
the patients had severe TB. There was no difference of 
baseline characteristics among the 4 groups of patients 
except for the  p ro p o rtio n  of p a tien ts  w ith  cavities 
(Table 1).
In total 237 patients delivered all required sputum sam­
ples and of good quality and the rest was considered as 
missing data. As shown in table 1, mean sputum conver­
sion time of the zinc + vitamin A intervention group was 
the shortest, and that of the zinc intervention group the 
longest. The zinc + vitamin A (n = 50) and vitamin A 
groups (n = 56) showed less weeks to reach 85% of spu­
tum  conversion, followed by the placebo group (n = 62). 
The zinc supplem entation group (n = 68) showed the
Enter into zinc group (76) 
i ------
Withdrawn from study 0-2 
month
• Pregnancy (1 )
• Lost to follow up (5)
• Died(1)
69 patients at 2 month
Withdrawn from study 2-6 
month
• Lost to follow up (4)
• Died (2)
Completed treatment at 6 
month (63)
Eligible for study (300)
Enter into vitamin A 
group (72)
Withdrawn from 
study 0-2 month
• Lost to follow 
up (4)
• Died (2)
66 patients at 2 
month
I
Withdrawn from 
study 2-6 month
• Lost to follow 
up (6)
• Died (1)
Completed 
treatment at 6 
month (59)
Enter into vitamin A + zinc 
group (66)
Withdrawn from study 0-2 
month
• Lost to follow up (7)
• Died (2)
57 patients at 2 month
Withdrawn from study 2-6 
month
• Lost to follow up (1)
Completed treatment at 6 
month (56)
Enter into placebo 
group (86)
Withdrawn from study 
0-2 month
• Lost to follow up
(2)
• Died (2)
82 patients at 2 month
Withdrawn from study 
2-6 month
• Lost to follow up 
(5)
Completed treatment 
at 6 month (77)
F igure  1 Trial profile. Including reasons for patients' drop out during the study.
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Table 1 Changes on sputum smear AFB and radiograph after 2 and 6 months
Variables Groups
Zinc Vitam in A Vitam in A + Zinc Placebo
Age (year), mean ± SD 30.9 ±11.8 33.1 ± 11.5 30.1 ± 12 31.4 ± 10.4
Gender (n,%):
Male 51 (67.1) 46 (63.9) 42 (63.6) 50 (58.1)
Female 25 (32.9) 26 (36.1) 24 (36.4) 36 (41.9)
Sputum smear grade (n,%):
+ 1 18 (23.7) 22 (30.6) 25 (37.9) 24 (27.9)
+ 2 24 (31.6) 19 (26.4) 18 (27.3) 30 (34.9)
+ 3 34 (44.7) 31 (43) 23 (34.8) 32 (37.2)
Sputum conversion time (wk), mean ±SD 3.02 ± 2.2 2.1 ± 1.6 1.94 ± 1.4 2.5 ± 1.7
Duration to achieve WHO target(wk), mean t 6.6 4.0 4.0 5.0
Number of cavity (n,%)
0 month* 18 (25.7) 35 (51.5) 25 (38.5) 36 (41.9)
2 month* 5 (7.5) 17 (27) 8 (14.8) 13 (17.1)
6 month 5 (8.1) 3 (5.3) 2 (3.6) 3 (4.2)
Cavity surface area (cm2), median (IQR)
0 month 10.2 (4.9-17.4) 12.0 (6.2-22.1) 12.9 (4.8-15.9) 10.2 (4.9-21.6)
2 month 6.2 (2.5-21)+ 5.5 (2.5-13.7)+ 5.9 (2-16.2)+ 4 (3.1-10)+
6 month
+H0)(00 0 0 + 0 (0- 0)+ 0 0 +
Totallesion area (cm2), median (IQR)
0 month 120 (71-179.8) 139 (44-216) 143 (73-198) 129 (62-209)
2 month 40.5 (12-100)+ 35 (0-80)+ 37 (9-94.5)+ 32.5 (4.5-77.5)+
6 month 0 (0-42.4)+ 0 (0-25.8)+ 0 (0-21)+ 0 (0-25.8)+
SD = standard deviation, IQR = interquartile range; ^significant difference of proportion between groups (chi-squared, p < 0.05); significant changes from baseline 
p < 0.001 +; number of good quality sputum analyzed for zinc, vitamin A, zn + vitamin A and placebo groups were: 62, 57, 50, and 68 respectively (total 237). 
tWHO target: 85% subjects in a group converted into SS negative.
longest time to reach 85% of sputum  conversion. How­
ever, no significant difference of the sputum  conversion 
time was observed between groups (ANCOVA, p > 0.05). 
Factors included in the analysis were AFB level, compli­
ance, and the differences of zinc and retinol level from 
the baseline. After one week, sputum was smear negative 
in 58.5% of patients from the zinc + vitamin A group, in 
45.6% of patients in the vitamin A and placebo groups, 
whereas the zinc group showed the lowest percentage 
(35.3%). The zinc + vitamin A (n = 50) and vitamin A 
groups (n = 56) showed less weeks to reach 85% of spu­
tum  conversion, followed by the placebo group (n = 62). 
The zinc supplem entation group (n = 68) showed the 
longest time to reach 85% of sputum  conversion. After 
two m onths no significant differences were found 
between the groups (Figure 2). Taking into account the 
W HO success rate target of 85% conversion to negative, 
we observed that patients in the zinc + vitamin A supple­
mentation group reached the target within 4 weeks, simi­
lar to the vitamin A group, followed by placebo group 
(5 weeks), and zinc group (6.6 weeks).
Mean BMI for the four groups varied from 16.4 - 16.6 
and was 16.5 for all 300 patients, indicating severe mal­
n u tritio n  (Table 2). Fifty percen t of the patien ts had 
BMI lower than 16.5 Kg/m2 when enrolled in the study;
the rest was m oderate m alnutrition  (33%) and norm al 
nutritional status (17%). The mean value of MUAC and 
percentage body fat were extremely low.
After 2 m onths of treatm ent, there were significant 
im provem ents of m icronu trien t status w ithin groups 
compared with the initial levels, particularly in patients 
given combined vitamin A and zinc supplementation or 
placebo (Table 3). The proportion  of cavities on chest 
x-ray was significantly different between the four groups 
bu t no t after 6 m onths of trea tm en t (Table 1). The 
changes of the p roportions betw een groups however, 
were not significant. At the end of treatment, significant 
changes from the baseline were observed for all variables 
except for zinc concentration in the group receiving vita­
min A and the group receiving zinc + vitamin A, but no 
difference between groups was observed (Table 1).
Discussion
In this double-blind random ized com m unity trial, sup­
plem entation with zinc and vitam in A, either alone or 
combined, failed to show superiority over placebo. This 
was unexpected, as we could not confirm the results of 
the previous study in Jakarta, in which vitam in A and 
zinc supplementation was beneficial in terms of sputum  
conversion time [2]. Results similar to ours with regard
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Figure  2 Cum ulative percentage of the sputum conversion time. The zinc + vitamin A (n = 50) and vitamin A groups (n = 56) showed less 
weeks to reach 85% of sputum conversion, followed by the placebo group (n = 62).
Table 2 Changes of anthropometric measurements prior to, at two and six months of treatment
Variables Groups
Zinc Vitam in A Zinc+ Vit A Placebo
BMI(kg/m2), mean ± SD
0 month 16.5 ± 2.2 16.5 ± 2.2 16.6 ± 2.1 16.4 ± 2.5
2 month 17.7 ± 2.3+ 17.8 ± 2.2+ 17.7 ± 2.0+ 17.5 ± 2.4+
6 month 18.5 ± 2.22+ 18.1 ± 2.42+ 18.3 ± 2.02+ 18.4 ± 2.62+
Increasing BM Ifrom  the baseline 
(kg/m2), mean ± SD
0 to 6 month 1.9 ± 1.3 1.7 ± 1.6 1.9 ± 1.5 2.0 ± 1.4
MUAC (cm), median (IQR)
0 month 21.1 (19.8-23.1) 21 (20-23) 21.3(20-23.6) 21.8(19-23.6)
2 month 23 (21-25)+ 22 (20.1-24.7)+ 23 (21-24)+ 23 (20.8-24.5)+
6 month 24 (22.5-25.1)+ 23.0 (21.8-25.0)+ 24.0 (22.0-25.3)+ 24 (22.5-26)+
Body fat (%),mean ± SD
0 month 11 ±4.5 11 ±6.2 10.8 ± 4.7 11.9 ± 5.9
2 month 12.9 ± 5.0+ 13.3 ± 5.9+ 12.9 ± 5.1 + 14.2 ± 6.1 +
6 month 14.5 ± 5.82+ 14.2 ± 6.42+ 14.2 ± 6.42+ 16.0 ± 6.32+
SD =  standard deviation, IQR =  interquartile range, significant changes from baseline, paired student-T +p < 0.001.
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Table 3 Changes in blood parameters prior to, at two and six months of treatment
Variables Groups
Zinc Vitam in A Zinc+ V it A Placebo
Plasma CRP (mg/L), median (IQR)
0 month 25.7 (13.7-38.8) 27.9 (11.5-42.1) 29.1 (12.6-43.0) 30.9 (13.3-47.4)
2 month 4.6 (1.4-13.8) + 4 (1-14.3)+ 4.2 (1.3-15.5) + 6.4 (1.5-14.6) +
6 month 1.3 (0.5-2.7)+ 1.5(0.6-3.3)+ 1.1 (0.5-4.4) + 1.7 (0.9-40)+
Serum albumin (g/dL), mean ± SD
0 month 3.8 ± 0.84 4.0 ± 0.75 4.0 ±0.96 3.8 ± 0.83
2 month 4.5 ± 0.68+ 4.3 ± 0.88t 4.4 ± 0.74 4.4 ± 0.78+
6 month 4.6 ± 0.52+ 4.6 ± 0.72+ 4.7 ± 0.62+ 4.6 ± 0.52+
Leukocytes(cells/mm3),median (IQR)
0 month 9300 (7575-13000) 9750 (7775-11575) 10200 (7475-12250) 9750 (7000-2225)
2 month 6700 (5400-8100)+ 6600 (5600-8050)+ 7500 (5500-8875)+ 7300 (5900-9100)+
6 month 6000 (5100-7000)+ 6900 (5275-8100)+ 6800 (5850-7800)+ 6800 (5800-8100)+
ESR (mm),median (IQR)
0 month 73.0 (48.0-99.5) 59.5 (40.0-88.5) 62.0 (36.0-92.0) 75.0 (42.0-109.0)
2 month 28 (16-40)+ 31 (18-40)+ 30 (17.3-38.8)+ 28 (16-45)+
6 month 11 (4-28)+ 14 (8-28.8)+ 12 (6-28)+ 11 (8-28)+
Hemoglobin(g/dL), mean ± SD
0 month 11.2 ± 2.7 11.6 ± 2.4 11.6 ± 2.5 11.0 ± 2.5
2 month 12.5 ± 2.78+ 12.6 ± 2.55+ 13.18 ± 2.48+ 12.12 ± 2.43+
6 month 12.8 ± 2.3+ 13.0 ± 2.2+ 13.3 ± 2.2+ 12.8 ± 2.3+
Plasma zinc(|jmol/L), mean ± SD
0 month 11.6 ± 2.2 11.9 ± 3 12.1 ± 3.0 11.8 ± 2.4
2 month 11.7 ± 2.43t 11.6 ± 1.83+ 12.5 ± 2.33+ 11.7 ± 2.33+
6 month 13.1 ± 1.92t 12.5 ± 2.1 t 12.8 ± 2.9t 12.6 ± 1.7 3+
Plasma retinol(|jmol/L), median (IQR)
0 month 0.7(0.5-1.0) 0.7(0.5-1.5) 0.7(0.4-1.1) 0.7 (0.5-1)
2 month 1.2 (1-1.6)a+ 1.5(1-2)ab+ 1.3 (1-1.9)+ 1.2 (0.9-1.6)b+
6 month 1.4 (1.1-1.9)t 1.6 (1.2-2.0)+ 1.6 (1.2-1.9) 1.4 (1.0-1.8)+
SD = standard deviation, IQR = interquartile range, ^significant difference of proportion between groups (chi-squared, p < 0.05), significant changes from baseline 
p < 0.051 and p < 0.001+, ab significant changes between group (One-way ANOVA, p < 0.05).
to  zinc supplem entation  were obtained in a study in 
Tanzania [15], where such supplementation did not lead 
to a reduction of sputum  conversion time compared to 
supplem entation with a m ulti-m icronutrient or placebo 
e ither. Also, zinc sup p lem en ta tio n  did n o t im prove 
immune response among TB patients infected with HIV 
in a study in Singapore [16]. The authors further con­
cluded that in the absence of zinc deficiency, additional 
zinc supp lem entation  was no t beneficial. A nd to the 
best of our knowledge, the data on the effect of vitamin 
A supplementation in TB were inconclusive [17-19].
How can we explain the d iscrepancy  betw een  the 
resu lts of the Jakarta study  and the cu rren t results? 
The first explanation might be found in retinol concen­
trations and inflam m atory response at baseline. In the 
Jakarta study, h igher m ean  re tin o l con cen tra tio n s 
(0.8 ^mol/L and 0.9 ^m ol/L for the supplem ented and 
placebo groups, respectively) were found than  in the 
current study (0.7 ^mol/L for all groups) [2]. The mean
baseline CRP co n cen tra tio n s in  the  Jakarta study  
(53 mg/L for the m icronutrient group and 44.1 for the 
placebo group) were almost twice as high as in the cur­
re n t study  (m ean CRP for all g roups = 28.4 m g/L). 
Higher CRP concentrations reflect a stronger inflamma­
tory response, which is known to lower the plasma reti­
nol concentrations [20]. Thus, the patients in the Jakarta 
study may have had a lesser degree of vitam in A defi­
ciency, inflam m ation leading to the low plasma retinol 
levels. This might imply that higher dosages of vitamin 
A supplem entation would have been needed for the TB 
patients of the current study to reach retinol concentra­
tions necessary for a clinical effect. This was also proven 
by the concentration  of retinol at 2 and 6 m onths of 
intervention, which could not elevate the retinol level in 
the plasm a. This is in line w ith the study in Malawi 
which concluded that supplem entations at the level of 
recommended daily allowance (RDA) did not meet their 
main outcomes [21]. In contrast with this, the study in
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Tanzania which used m ultim icronutrient supplem enta­
tions four to ten tim es higher than the RDA, reduced 
TB recurrences among the HIV-positive adults with TB, 
and increased T-cell counts of the HIV-negative patients 
[22]. W ith regard to zinc on the other hand, the level at 
baseline were already slightly above the deficiency cut 
off (10.7 ^mol/L). This may explain the lack of efficacy 
observed for zinc [2].
The second explanation may be connected to the dif­
ferences in the chest radiographs and the grading of 
sputum  AFB positivity, an im portant predictor of spu­
tum  conversion [23]. The num ber of patients with cav­
ities in  ou r study  was sim ilar (38%) to  th a t in  the 
Jakarta study (37.5% of to tal patien ts in both  group). 
M ore im portant however, is that in the present study, 
the proportion of patients with cavities among the four 
groups differed significantly at baseline (Table 1), with 
the highest proportion of cavities (51.5%) being present 
in the patients of the vitamin A supplementation group. 
This imbalance may have obscured the effect of vitamin 
A supplem entation but would no t explain the lack of 
effect in the zinc + vitamin A group. Findings of a Span­
ish study showed the association between the presence 
of cavity and the conversion tim e in  the presence of 
HIV co-infection. It was concluded th a t cavity p ro ­
longed the conversion time, and the presence of HIV 
lowered the prevalence of cavity production in the lungs 
as captured in the chest x-ray. Thus, the absence (prob­
ably very small proportion) of HIV co-infection in the 
current study led to cavity formation in the lung and at 
the end prolonged the conversion time [24].
The severity of TB in our patients is witnessed by the 
fact that 40% had sputum  AFB positivity grade 3 prior 
to  tre a tm e n t w hereas in the  Jakarta study  68% had 
grade 1 (for bo th  supplem ented and placebo groups) 
and this can be expected to lead to longer sputum  con­
version time [23]. It may be tha t the supplem entation 
effect does not become clear in such severe cases.
The th ird  explanation for the difference between the 
current study and the previous study in Jakarta is related 
to the sample size. In Jakarta, the sample size was esti­
mated "on the ability to determine a difference of retinol 
cosentration in plasma, with an alpha = 0.05 and 1-beta = 
0.95 with use of a one-tailed test for concentrations of 
hemoglobin in blood, and of retinol and zinc in plasma.” 
[2] The findings in the Jakarta trial, of an effect of zinc 
+vitamin A supplem entation on the sputum  conversion 
time was unexpected as no sample size was estimated for 
this specific outcome. In the present study, designed for 
confirmation of the previous results, the effect on sputum 
conversion time was not found. Thus, the probability is 
real that the finding in the first study was not valid, due to 
underpowerm ent of the study to measure a difference in 
sputum conversion time.
Another explanation may be related to the observation 
that the patients in the current study were m ore m al­
nourished than the patients in the Jakarta study. Mean 
BMI of our cohort was 16.5 Kg/m2 as compared to 18.5 
Kg/m2 in the Jakarta study [2]. There was no available 
population based study on adult m alnutrition, however 
a recent study found 33% of under nu trition  occurred 
among neighbors of the TB patients [25]. Such a low 
BMI may reflect two processes. One would be protein 
energy malnutrition (which severely affects host defense) 
and the other wasting due to the catabolism induced by 
the acute phase response [26]. As found in our subjects, 
the BMI increased along with reducing of inflammation. 
W hen the patien ts got healed, as show n in the to tal 
lesion area of lung, they gained more weight and also of 
other m icronutrients, such as iron, zinc and vitamin A. 
(table 1 and 3) This might explain how the hemoglobin 
increased, although it was still in the borderline to be 
considered normal.
Neither of low intake or wasting is directly affected by 
supplem entation  of m icronu trien ts and hence it may 
no t be rem arkable tha t we failed to show an effect in 
this study. Beside m acronutrient deficiencies, there was 
also the possibility that additional m icronutrients defi­
ciency w ere p resen t in  the  study  popu la tion , w hich 
could not be corrected with zinc and vitamin A.
For exam ple, v itam in  D has been im plicated  in 
defense against TB, but vitamin D deficiency is a world­
wide problem . F u rtherm ore  th ere  m ight be a link 
betw een vitam in D deficiency w ith  ethnicity . In the 
Jakarta study, the patients were mainly from Java, Sunda 
and Sum atra, w ith a m inority  of o thers, the  cu rren t 
study consists mainly of patients indigenous to Tim or 
and Rote islands [27]. We found in the same study areas 
that ethnicity was associated w ith the developm ent of 
TB and severity of TB [28,29]. In line with this, a recent 
study show ed th a t v itam in D recep to r genetic poly­
m orphism s were associated w ith the tim e to  sputum  
culture conversion [30]. Also it was shown that vitamin 
D receptor genotype independently predicted the spu­
tum  sm ear conversion tim e while on anti-TB therapy 
[31]. One m ight speculate that ethnic background also 
plays a role in the response to supplem entation  w ith 
micronutrients.
W e conclude th a t the patien t groups stud ied  here, 
were suffering from severe tuberculosis with cavities in 
at least one third of the patients, and high sputum  posi- 
tivity grade. The p atien ts  were v itam in A deficiency 
whereas zinc was at borderline but sufficient to support 
the im m une system and perhaps m ore im portant, also 
severely m alnourished. It was also im portant to notice 
that the supplem entation could not elevate the level of 
re tin o l and zinc p lasm a h igher th an  its borderline. 
Against this background we were not able to replicate
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the results of the Jakarta study that demonstrated a ben­
eficial effect of vitamin A and zinc in tuberculosis. This 
m eans that the previous findings in Jakarta cannot be 
generalized. For further studies, a larger sample size will 
be required, and higher dosages of the zinc and vitamin 
A sup p lem en ta tio n s shou ld  be considered. Also, in 
patients with very low BMI, the effect of protein supple­
mentations needs further study.
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